EGFR L858R and PIK3CA H1047R mutations in pulmonary adenocarcinoma - diagnosis in liquid biopsy

被引:0
|
作者
Sousa, V. [1 ]
Alarcao, A. [1 ]
Ladeirinha, A. F. [1 ]
Silva, M. Reis [1 ]
Ferreira, T. [1 ]
Rodrigues, A. [1 ]
Vilasboas, C. [1 ]
Figueiredo, A. [1 ]
Barata, F. [1 ]
Almeida, R. [1 ]
Almeida, V. [1 ]
Carvalho, L. [1 ]
机构
[1] CHUC, IAP PM, FMUC, Coimbra, Portugal
关键词
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
E-PS-17-01
引用
收藏
页码:S334 / S334
页数:1
相关论文
共 50 条
  • [1] Identification of effective natural PIK3CA H1047R inhibitors by computational study
    Liu, Naimeng
    Wang, Xinhui
    Li, Xuan
    Lv, Xiaye
    Xie, Haoqun
    Guo, Zhen
    Wang, Jing
    Dou, Gaojing
    Du, Ye
    Song, Dong
    AGING-US, 2021, 13 (16): : 20246 - 20257
  • [2] PIK3CA H1047R Mutant Subpopulations in Normal Breast and Breast Tumors
    Myers, M. B.
    Banda, M.
    McKim, K. L.
    Wang, Y.
    Parsons, B. L.
    ENVIRONMENTAL AND MOLECULAR MUTAGENESIS, 2014, 55 : S62 - S62
  • [3] Investigation into the influence of the H1047R PIK3CA mutation on the bioenergetic dependency of a cell
    Foster, Rebecca
    Rigby, Sue
    Christopherson, Cindy
    Sninsky, John
    Kwok, Shirley
    Torrance, Chris
    CANCER RESEARCH, 2011, 71
  • [4] Luminal Expression of PIK3CA Mutant H1047R in the Mammary Gland Induces Heterogeneous Tumors
    Meyer, Dominique S.
    Brinkhaus, Heike
    Mueller, Urs
    Mueller, Matthias
    Cardiff, Robert D.
    Bentires-Alj, Mohamed
    CANCER RESEARCH, 2011, 71 (13) : 4344 - 4351
  • [5] Investigating the Structure and Dynamics of the PIK3CA Wild-Type and H1047R Oncogenic Mutant
    Gkeka, Paraskevi
    Evangelidis, Thomas
    Pavlaki, Maria
    Lazani, Vasiliki
    Christoforidis, Savvas
    Agianian, Bogos
    Cournia, Zoe
    PLOS COMPUTATIONAL BIOLOGY, 2014, 10 (10)
  • [6] Investigating the structure and dynamics of the PIK3CA wild-type and H1047R oncogenic mutant for potential allosteric modulation
    Gkeka, Paraskevi
    Papafotika, Alexandra
    Christoforidis, Savvas
    Cournia, Zoe
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 249
  • [7] Association of PIK3CA H1047R and STK11 F354L mutations with response to neoadjuvant chemoradiotherapy and survival in esophageal cancer.
    Hsu, Po Kuei
    Chou, Teh-Ying
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [8] A Patient With Metastatic Lung Adenocarcinoma Harboring Concurrent EGFR L858R, EGFR Germline T790M, and PIK3CA Mutations: The Challenge of Interpreting Results of Comprehensive Mutational Testing in Lung Cancer
    Lammers, Philip E.
    Lovly, Christine M.
    Horn, Leora
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2014, 12 (01): : 6 - 11
  • [9] Detection of H1047R and E545K PIK3CA mutations from peripheral blood in ER positive breast cancer patients
    Garcia-Saenz, Jose Angel
    Acosta, Daniel
    Moreno, Fernando
    Ayllon, Paticia
    Sotelo, Miguel
    Caldes, Trinidad
    Diaz-Rubio, Eduardo
    Romero, Atocha
    CANCER RESEARCH, 2015, 75
  • [10] Treatment response to idelalisib in a patient with immunodeficiency-associated Burkitt lymphoma harboring a PIK3CA H1047R mutation
    Annalen Bleckmann
    Sascha Dierks
    Hans-Ulrich Schildhaus
    Niels Hellige
    Ulrike Bacher
    Lorenz Trümper
    Gerald Wulf
    Annals of Hematology, 2021, 100 : 277 - 279